Literature DB >> 20382798

IL-4 and IL-13 dual antagonism: a promising approach to the dilemma of generating effective asthma biotherapeutics.

Larry Borish.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382798     DOI: 10.1164/rccm.201002-0147ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

Review 1.  Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations.

Authors:  Rakesh K Kumar; Paul S Foster; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2014-06-05       Impact factor: 4.962

Review 2.  The immunology of asthma: Asthma phenotypes and their implications for personalized treatment.

Authors:  Larry Borish
Journal:  Ann Allergy Asthma Immunol       Date:  2016-08       Impact factor: 6.347

Review 3.  Interleukin 4: Its Role in Hypertension, Atherosclerosis, Valvular, and Nonvalvular Cardiovascular Diseases.

Authors:  Kamal M Kassem; Mahboob Ali; Nour-Eddine Rhaleb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-08-11       Impact factor: 2.457

4.  A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma.

Authors:  Rabih Halwani; Asma Sultana Shaik; Elaref Ratemi; Sibtain Afzal; Rosan Kenana; Saleh Al-Muhsen; Achraf Al Faraj
Journal:  Exp Mol Med       Date:  2016-10-07       Impact factor: 8.718

5.  Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma.

Authors:  Melissa M Bunting; Alexander M Shadie; Rylie P Flesher; Valentina Nikiforova; Linda Garthwaite; Nicodemus Tedla; Cristan Herbert; Rakesh K Kumar
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.